0000899243-18-027381.txt : 20181024 0000899243-18-027381.hdr.sgml : 20181024 20181024170326 ACCESSION NUMBER: 0000899243-18-027381 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181018 FILED AS OF DATE: 20181024 DATE AS OF CHANGE: 20181024 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chereau Frederic CENTRAL INDEX KEY: 0001640592 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38707 FILM NUMBER: 181136980 MAIL ADDRESS: STREET 1: C/O ATYR PHARMA, INC. STREET 2: 3545 JOHN HOPKINS COURT, SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LogicBio Therapeutics, Inc. CENTRAL INDEX KEY: 0001664106 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 471514975 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 61(0)428-338-594 MAIL ADDRESS: STREET 1: 700 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2018-10-18 2018-10-22 0 0001664106 LogicBio Therapeutics, Inc. LOGC 0001640592 Chereau Frederic C/O LOGICBIO THERAPEUTICS, INC. 610 MAIN ST., 3RD FLOOR CAMBRIDGE MA 02139 1 1 0 0 President, CEO Employee Stock Option (right to buy) 10.00 2018-10-18 4 A 0 155000 0.00 A 2028-10-17 Common Stock 155000 155000 D The option becomes exercisable in equal one forty-eighth installments from the vesting commencement date, October 18, 2018. The Form 4, as originally filed, incorrectly reported the number of derivative securities acquired, the amount of underlying securities and the number of derivative securities beneficially owned. The Form 4, as amended by this Form 4/A, correctly reports such information. /s/ Matthias Jaffe, as Attorney-in-Fact 2018-10-24